Transcript of learning module Preventing complications in patients with type 2 diabetes (Dur: 09' 40") Duration: 0:09:40
|
|
- Silas Daniels
- 5 years ago
- Views:
Transcription
1 Transcript of learning module Preventing complications in patients with type 2 diabetes (Dur: 09' 40") Contributor: Vinod Patel Available online at: Duration: 0:09:40 Vinod: Diabetes and its management consumes around 10% of the entire NHS budget and a lot of this is around the complications of diabetes. For example, end stage renal failure is the commonest cause of patients needing dialysis programmes in this country. Diabetic retinopathy is the commonest cause of blindness under the age of 65. Strokes and heart disease is increased at least twoto fourfold in patients with diabetes. However, there s very good news. With good care planning, patient education, and a multi-factoral approach we can actually reduce all the complications of diabetes by well over 50%. Diabetic nephropathy is now the commonest single reason for patients going onto end stage renal replacement programmes. We can prevent this by early aggressive management of the hypertension, especially by using agents such as ACE inhibitors and the angiotensin II receptor antagonists.
2 Diabetic neuropathy we often don t think about neuropathy, however we know that it has a devastating effect on a patient s quality of life. By this we mean erectile dysfunction and also painful peripheral neuropathy. Once again, if these conditions are picked up early enough, maybe we can prevent them by management of risk factors, particularly smoking, and there are also very good treatments now available for these individual complications. Diabetic retinopathy is now the commonest cause of blindness under the age of 65 in the UK population. If we can pick the early types of diabetic retinopathy sufficiently early on in their natural history then we can intervene and stop them going on to sight threatening retinopathy. This includes management of clinical risk factors such as hypertension and poor glycaemic control. If patients are sufficiently advanced in their retinopathy then laser treatment will be needed. Patients with type 2 diabetes have at least two- to fourfold increase in the risk of heart disease, that is ischaemic heart disease, leading to heart attacks and angina. But they also have an increased risk of stroke. Once again, the way to manage these complications is to treat the risk factors early on, and with macrovascular disease, it s going to be the hypertension and the dyslipidaemia particularly. With respect to dementia, I think we re realising that a lot of our patients with dementia actually have type 2 diabetes. Type 2 diabetes would increase your risk of dementia because of its association with multiple strokes. What are the risk factors for the multiple strokes? They will be poor blood pressure control and the poor control of an abnormal lipid profile. So once again we have to be aggressive and treat these risk factors to reduce strokes and to reduce dementia. 2
3 The overall approach to all these complications should be focused on a multi-professional approach where we re looking at all the risk factors as a bundle. If you treat them all, then the evidence suggests that you can reduce all of them significantly. One of the best studies that we have in this regard is a Steno-2 study that came out in Denmark. What they showed was that if you aim towards a blood pressure of around 130 systolic, a total cholesterol of 4 or under and good glycaemic control, together with the appropriate use of agents such as ACE inhibitors, statins, and aspirin, then you can reduce all the complications of diabetes by at least 50%. Statins, for example, in large randomised controlled trials have been shown to reduce cardiovascular risk by at least 25% and cardiovascular events by around the same amount as well. And we can use agents that are generic such as simvastatin 40, to achieve this in the vast majority of cases. ACE inhibitors and some angiotensin II receptor antagonists are now also generic and they have been shown to reduce risk of stroke by a third, and even risk of kidney disease by around 25% as well. The use of aspirin in patients with type 2 diabetes has become a bit more controversial recently. In terms of secondary prevention for ischaemic heart disease or stroke, it is obviously the treatment of choice if the patient can tolerate it. However, for primary prevention, the most recent metaanalysis shows that we should probably only focus on a patient who has a cardiovascular risk of more than 10% over the next 10 years. In people at a lower risk of 5% or under, we should probably not use aspirin because the disbenefits are going to be much higher than the actual benefits in this group of patients. If we wanted to summarise an overall approach to reducing complications in patients with diabetes, they would have to focus on two or three main areas. The most important area is patient 3
4 education and care planning. You need to have an engaged patient who knows their future risks and how to prevent them. The more we educate our patients, they are more likely to engage with their targets for management and also to be concordant with the treatment that we are recommending. So if the patient understands, they can look after themselves. It s very important to remember that because the patient with diabetes only sees healthcare professionals for three hours in a whole year. The other 8700 or so hours, they are on their own. So we must focus on care planning. There are lots of care plans out there but in essence, they summarise what the healthcare team is trying to achieve and hopes that the patient will engage in planning their own care. This is so that the patient can focus on the risk factors that they really want to concentrate on. They may be risk factors that they are having difficulty achieving, but we may need to leave them aside for the time being and then concentrate on the ones that we can do something about. In terms of care planning, what we often forget is how well the patients are actually doing. Because nobody will be scoring 0 as it were on all their risk factors. A lot of people will be desperately trying to look after themselves with their diet, incorporating physical activity into their everyday life, and a lot of people are now giving up smoking as well. So people must be congratulated on what they are doing well, but we must give a clear steer on their main risk factors that can affect their future life and particularly increased risk of complications. What I often try to do is concentrate on what the patient is actually doing well, so I ll use models such as this here, where we ll say to the patient, Look, you re now in the green zone, your chances of 4
5 having heart attacks and strokes has gone down considerably, look how small these columns are in comparison to where you were six months ago, when your risk was much higher, when your blood pressure was higher, and your diabetes control was poorer. This is based on the UKPDS risk model for diabetes complications. So the key messages when it comes to caring for patients with type 2 diabetes have to be based on patient education and care planning, and the approach must be individualised to the patient. In terms of strategies to reduce future complications, we must look out for the early warning signs of complications. These will be picked up in various settings, for example, the optician might say Have you got diabetes? when they come to get their new glasses. But we must also screen for early complications such as microalbuminuria, make sure patients have retinal screening, and make sure that they have their feet examined on a regular basis. Thereafter we have to optimise the pharmacological management, and this will be based around evidence based treatments, such as the statins, the ACE inhibitors, and the aspirins if appropriate for that patient. The final bit is to make sure that your patient is engaged with the healthcare system so they know how to navigate through it and they know how to ask for help if they need it. BMJ Learning
Complications of Diabetes: Screening and Prevention
Complications of Diabetes: Screening and Prevention Dr Steve Cleland Consultant Physician GGH and QEUH Diabetes Staff Education Course June 17 Diabetic Complications Microvascular: Retinopathy Nephropathy
More informationDiabetes Prevention & Management of Complications
Diabetes Prevention & Management of Complications Dr Ketan Dhatariya Consultant in Diabetes and Endocrinology NNUH The Planet is Changing IFCC (mmol/mol) = (current value (%) * 10.93) - 23.50 (reported
More informationComplications of Diabetes mellitus. Dr Bill Young 16 March 2015
Complications of Diabetes mellitus Dr Bill Young 16 March 2015 Complications of diabetes Multi-organ involvement 2 The extent of diabetes complications At diagnosis as many as 50% of patients may have
More informationWhy is Earlier and More Aggressive Treatment of T2 Diabetes Better?
Blood glucose (mmol/l) Why is Earlier and More Aggressive Treatment of T2 Diabetes Better? Disclosures Dr Kennedy has provided CME, been on advisory boards or received travel or conference support from:
More informationPreventive Cardiology Scientific evidence
Preventive Cardiology Scientific evidence Professor David A Wood Garfield Weston Professor of Cardiovascular Medicine International Centre for Circulatory Health Imperial College London Primary prevention
More informationLiving with Diabetes Living with diabetes
Living with Diabetes Living with diabetes Professor David Mathhews Before the turn of the last century, Type 1 diabetes where you ran out of insulin altogether would be entirely fatal. And the first real
More informationANAEMIA MANAGEMENT: HOW AND WHY DOES ERBP DIFFER FROM KDIGO Francesco Locatelli, Lecco, Italy
ANAEMIA MANAGEMENT: HOW AND WHY DOES ERBP DIFFER FROM KDIGO Francesco Locatelli, Lecco, Italy Chair: Kai- Uwe Eckardt, Erlangen, Germany Pierre- Yves Martin, Geneva, Switzerland Prof. Francesco Locatelli
More informationOutcomes of diabetes care in England and Wales. A summary of findings from the National Diabetes Audit : Complications and Mortality reports
Outcomes of diabetes care in England and Wales A summary of findings from the National Diabetes Audit 2015 16: Complications and Mortality reports About this report This report is for people with diabetes
More informationMetformin should be considered in all patients with type 2 diabetes unless contra-indicated
November 2001 N P S National Prescribing Service Limited PPR fifteen Prescribing Practice Review PPR Managing type 2 diabetes For General Practice Key messages Metformin should be considered in all patients
More informationScottish Diabetes Survey
Scottish Diabetes Survey 2008 Scottish Diabetes Survey Monitoring Group Foreword The information presented in this 2008 Scottish Diabetes Survey demonstrates a large body of work carried out by health
More informationYou re listening to an audio module from BMJ Learning. Hallo. I'm Anna Sayburn, Senior Editor with the BMJ Group s Consumer Health Team.
Transcript of learning module Shared decision making (Dur: 26' 13") Contributors: Anna Sayburn and Alf Collins Available online at: http://learning.bmj.com/ V/O: You re listening to an audio module from
More informationComplications of Diabetes: Screening and Prevention. Dr Martin McIntyre Consultant Physician Royal Alexandra Hospital Paisley
Complications of Diabetes: Screening and Prevention Dr Martin McIntyre Consultant Physician Royal Alexandra Hospital Paisley Diabetic Complications Microvascular: Retinopathy Nephropathy Neuropathy Macrovascular:
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE. Type 2 diabetes: the management of type 2 diabetes (update)
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Type 2 diabetes: the management of type 2 diabetes (update) 1.1 Short title Type 2 diabetes (update) 2 Background a) The National
More informationADVANCE post trial ObservatioNal Study
Hot Topics in Diabetes 50 th EASD, Vienna 2014 ADVANCE post trial ObservatioNal Study Sophia Zoungas The George Institute The University of Sydney Rationale and Study Design Sophia Zoungas The George Institute
More informationDr Tahseen A. Chowdhury Royal London Hospital. New Guidelines in Diabetes: NICE or Nasty?
Dr Tahseen A. Chowdhury Royal London Hospital New Guidelines in Diabetes: NICE or Nasty? I have no conflicts of interest I do not undertake talks / advisory bodies / research for any pharma company Consultant
More informationEMR as a Platform for Clinical Transformation
EMR as a Platform for Clinical Transformation Dr Vinod Patel MD for the Integrated Diabetes Team George Eliot NHS Hospital HIC16-26 July, 2016 Twitter: @vinodpatel12345 Overview of Talk The Burden of Diabetes
More informationDIABETES MEASURES GROUP OVERVIEW
2014 PQRS OPTIONS F MEASURES GROUPS: DIABETES MEASURES GROUP OVERVIEW 2014 PQRS MEASURES IN DIABETES MEASURES GROUP: #1. Diabetes: Hemoglobin A1c Poor Control #2. Diabetes: Low Density Lipoprotein (LDL-C)
More informationHypertension and diabetic nephropathy
Hypertension and diabetic nephropathy Elisabeth R. Mathiesen Professor, Chief Physician, Dr sci Dep. Of Endocrinology Rigshospitalet, University of Copenhagen Denmark Hypertension Brain Eye Heart Kidney
More informationABCD and Renal Association Clinical Guidelines for Diabetic Nephropathy-CKD. Management of Dyslipidaemia and Hypertension in Adults Dr Peter Winocour
ABCD and Renal Association Clinical Guidelines for Diabetic Nephropathy-CKD. Management of Dyslipidaemia and Hypertension in Adults Dr Peter Winocour Dr Indranil Dasgupta Rationale No national practical
More informationToledo Hospital Clinical Quality Indicators. Effective - Heart Attack
Effective - Heart Attack This page shows information on effective measures for patients who had heart attacks. "Effective care" means patients are given treatments that scientific evidence has shown leads
More informationSCREENING FOR DIABETES COMPLICATIONS
SCREENING FOR DIABETES COMPLICATIONS What is Good diabetes control? At clinic we measure the amount of glucose that has stuck to your red blood cells over that 3 month period (HbA1c). If blood glucose
More informationBeyond The Data: Promoting Well-being in Older Adults
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/grand-rounds-nation/beyond-data-promoting-well-being-olderadults/9844/
More informationSIGN 149 Risk estimation and the prevention of cardiovascular disease. Quick Reference Guide July Evidence
SIGN 149 Risk estimation and the prevention of cardiovascular disease Quick Reference Guide July 2017 Evidence ESTIMATING CARDIOVASCULAR RISK R Individuals with the following risk factors should be considered
More informationNR , CCNE: Reducing Your Risk for Type 2 Diabetes
NR-000-53, CCNE: Reducing Your Risk for Type 2 Diabetes Client-centered nutrition education uses methods like group discussions and hands-on activities to engage participants in learning. This outline
More informationCardiovascular risk reduction in diabetes Lipids (NICE CG181)
Cardiovascular risk reduction in diabetes Lipids (NICE CG181) Primary Prevention T1DM Offer Atorvastatin 20mg if >40 years old Diabetes duration >10 years Established nephropathy Other CVS risk factors
More informationDiabetic Nephropathy. Objectives:
There are, in truth, no specialties in medicine, since to know fully many of the most important diseases a man must be familiar with their manifestations in many organs. William Osler 1894. Objectives:
More informationCardiovascular Controversies: Exploring the ACC and AHA Guidelines on the Treatment of Blood Cholesterol
Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including
More informationMacrovascular Residual Risk. What risk remains after LDL-C management and intensive therapy?
Macrovascular Residual Risk What risk remains after LDL-C management and intensive therapy? Defining Residual Vascular Risk The risk of macrovascular events and microvascular complications which persists
More informationSurvey Scottish Diabetes. Survey Monitoring Group
Scottish Diabetes Survey 2009 Scottish Diabetes Survey Monitoring Group 2 Foreword The Scottish Diabetes Survey is now in its ninth year. This 2009 Survey, as with previous versions, continues to demonstrate
More informationRetinal Screening, Seeing Sense! Dinesh Nagi MBBS, PhD, FRCP Clinical Director Division of Medicine Mid- Yorkshire NHS Trust, Wakefield
Retinal Screening, Seeing Sense! Dinesh Nagi MBBS, PhD, FRCP Clinical Director Division of Medicine Mid- Yorkshire NHS Trust, Wakefield York Race Course 11 th Nov 2014 Presentation Importance of regular
More informationLatest Methods to Early Detection for Alzheimer's: Cognitive Assessments and Diagnostic Tools in Practice
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/alzheimers-disease-towards-earlier-detection/latest-methods-earlydetection-alzheimers-cognitive-assessments-and-diagnostic-tools-practice/8321/
More informationIs a Mediterranean diet best for preventing heart disease?
Is a Mediterranean diet best for preventing heart disease? By Peter Attia, M.D. This week an article titled Primary Prevention of Cardiovascular Disease with a Mediterranean Diet was featured in the New
More informationDiabetes Complications Guideline Based Screening, Management, and Referral
Diabetes Complications Guideline Based Screening, Management, and Referral Eric L. Johnson, M.D. Associate Professor Department of Family and Community Medicine Assistant Medical Director Altru Diabetes
More informationthree stories of ethnic communities coping with an epidemic Expert Interview: Dr. Rodney Hood
ealing with iabetes hosted by Pamela Wu three stories of ethnic communities coping with an epidemic Expert Interview: Dr. Rodney Hood Dr. Rodney Hood practices internal medicine in San Diego, California.
More informationNew indicators to be added to the NICE menu for the QOF and amendments to existing indicators
New indicators to be added to the for the QOF and amendments to existing indicators 1 st September 2015 Version 1.1 This document was originally published on 3 rd August 2015, it has since been updated.
More informationChronic Kidney Disease due to Diabetes (Diabetic Nephropathy)
Chronic Kidney Disease due to Diabetes (Diabetic Nephropathy) Patient information Oxford Kidney Unit If you have been told you have chronic kidney disease (CKD) due to diabetic nephropathy this leaflet
More informationBRAIN, EYES, HEART, KIDNEYS, LEGS KIDNEYS BRAIN, HEART, KIDNEYS BRAIN, EYES, HEART, KIDNEYS, LEGS COLOR ONE PART OF THE KIDNEY DON T COLOR ANYTHING
KIDNEYS Stan, a type 2 diabetic, has not kept his blood glucose under control. He noticed that his feet are gradually becoming swollen. The doctor orders a urine test, which reveals protein in his urine.
More informationDiabetes Control and Complications in Public Hospitals in Malaysia
ORIGINAL ARTICLE Diabetes Control and Complications in Public Hospitals in Malaysia Mafauzy M. FRCP For the Diabcare-Malaysia Study Group, Health Campus, Universiti Sains Malaysia, 16150 Kubang Kerian,
More informationStandard Operating Procedure 11. Completion of DAFNE Data Collection: Full Post Course Form F04.010, Version 8
Standard Operating Procedure 11 Completion of DAFNE Data Collection: Full Post Course Form F04.010, Version 8 Date Version Issue Review Contact Approved Date Date Person October 2013 9 October 2013 March
More informationRenal Protection Staying on Target
Update Staying on Target James Barton, MD, FRCPC As presented at the University of Saskatchewan's Management of Diabetes & Its Complications (May 2004) Gwen s case Gwen, 49, asks you to take on her primary
More informationHigh Blood Pressure Campaign 2017 Talking Points For Interviews & Other Opportunities
High Blood Pressure Campaign 2017 Talking Points For Interviews & Other Opportunities Basic Info What is high blood pressure? When a person has high blood pressure (also known as hypertension or HBP),
More informationInformation for people with diabetes. diabetes. glossary of. terms
Information for people with diabetes i diabetes glossary of terms Diabetes is a common condition, which most people have some understanding of, but when you listen to people talk about it, you may feel
More informationPractical Diabetes. Nic Crook. (and don t use so many charts) Kuirau Specialists 1239 Ranolf Street Rotorua. Rotorua Hospital Private Bag 3023 Rotorua
Practical Diabetes (and don t use so many charts) Nic Crook Rotorua Hospital Private Bag 3023 Rotorua Kuirau Specialists 1239 Ranolf Street Rotorua Worldwide rates of diabetes mellitus: predictions 80
More informationQuick tips: initiating insulin in type 2 diabetes in primary care video 2 START AUDIO
BMJ LEARNING VIDEO TRANSCRIPT Quick tips: initiating insulin in type 2 diabetes in primary care video 2 START AUDIO (Music) Martin Hadley-Brown: So usually when we re starting insulin, for someone with
More informationAddressing Vascular Plaque Ruptures
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/medical-breakthroughs-from-penn-medicine/addressing-vascularplaque-ruptures/3131/
More informationDisclosures. Diabetes and Cardiovascular Risk Management. Learning Objectives. Atherosclerotic Cardiovascular Disease
Disclosures Diabetes and Cardiovascular Risk Management Tony Hampton, MD, MBA Medical Director Advocate Aurora Operating System Advocate Aurora Healthcare Downers Grove, IL No conflicts or disclosures
More informationHEALTHY FOR LIFE: MEN AND HIV
Images in this document are stock photos. Posed by models. HEALTHY FOR LIFE: MEN AND HIV Nobody likes to think about the effects of ageing but it is helpful to know what to expect. This knowledge can help
More informationANAEMIA MANAGEMENT: THE KDIGO RECOMMENDATIONS Patrick S. Parfrey, St. John s, Canada
ANAEMIA MANAGEMENT: THE KDIGO RECOMMENDATIONS Patrick S. Parfrey, St. John s, Canada Chair: Kai- Uwe Eckardt, Erlangen, Germany Pierre- Yves Martin, Geneva, Switzerland Prof. Patrick S. Parfrey Division
More informationYOUR INFORMATION. Ischemic Heart Disease
YOUR INFORMATION Ischemic Heart Disease ISCHEMIC HEART DISEASE Your diagnosis You have been given a diagnosis of heart failure, which usually means your heart is working inefficiently. This inefficiency
More informationAspirin Resistance and Its Implications in Clinical Practice
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/clinicians-roundtable/aspirin-resistance-and-its-implications-in-clinicalpractice/3819/
More information21 Diabetic Myths Exposed
21 Diabetic Myths Exposed Disclaimer: Nothing in this ebook should be taken as complete medical advice. You should always seek the advice and treatment from certified and qualified medical personal. Contents
More informationType 2 diabetes in adults: controlling your blood glucose by taking a second medicine what are your options?
Patient decision aid Type 2 diabetes in adults: controlling your blood glucose by taking a second medicine what are your options? nice.org.uk/guidance/ng28 Published: December 2015 About this decision
More informationSUPPORTED LODGINGS. Providing a bridge to independent living for young people. Supported Lodgings
SUPPORTED LODGINGS Providing a bridge to independent living for young people Supported Lodgings A message from the supported lodgings team at Hull City Council Thank you for your interest. In our area
More informationType 1 diabetes in adults
Type 1 diabetes in adults Understanding NICE guidance information for people with type 1 diabetes, their families and carers, and the public Prepared for second consultation Type 1 diabetes information
More informationNHS Greater Glasgow & Clyde Managed Clinical Network for Diabetes
Guidelines for the Diagnosis of Diabetes Mellitus NHS Greater Glasgow & Clyde Managed Clinical Network for Diabetes Lead Authors: Dr Brian Kennon, Dr David Carty June 2015 Review due: December 2016 Diagnosis
More informationUpdate on Diabetes. Ketan Dhatariya. Why it s Not Just About Glucose Lowering Any More. Consultant in Diabetes NNUH
Update on Diabetes Why it s Not Just About Glucose Lowering Any More Ketan Dhatariya Consultant in Diabetes NNUH The Story So Far.. DCCT Retinopathy Neuropathy Nephropathy Intensive glucose control in
More informationESC GUIDELINES ON DIABETES AND CARDIOVASCULAR DISEASES
ESC GUIDELINES ON DIABETES AND CARDIOVASCULAR DISEASES Pr. Michel KOMAJDA Institute of Cardiology - IHU ICAN Pitie Salpetriere Hospital - University Pierre and Marie Curie, Paris (France) DEFINITION A
More informationI have high blood pressure, not hypertension. Wisconsin Health Literacy 8/3/2015
August 6, 2015 I have high blood pressure, not hypertension How health literacy affects what you do every day Steve Sparks Health Literacy Director Wisconsin Health Literacy Division of Wisconsin Literacy
More informationThe York Diabetes Care Model
This Session The York Diabetes Care Model The annual review what s it for and how to do it How to make the diagnosis of diabetes and who to test Categorisation of diabetes at diagnosis Basics of Insulin
More informationOur plan for giving better care to people with dementia Oxleas Dementia
Our plan for giving better care to people with dementia Oxleas Dementia 2013-2016 November 2013 1 Contents 1. What is our plan about? 2. Finding out if someone has dementia 3. Finding out the care and
More informationThe retinal renin-angiotensin system: implications for therapy in diabetic retinopathy
(2002) 16, S42 S46 2002 Nature Publishing Group All rights reserved 0950-9240/02 $25.00 www.nature.com/jhh : implications for therapy in diabetic retinopathy AK Sjølie 1 and N Chaturvedi 2 1 Department
More informationTreatment to reduce cardiovascular risk: multifactorial management
Treatment to reduce cardiovascular risk: multifactorial management Matteo Anselmino, MD PhD Assistant Professor San Giovanni Battista Hospital Division of Cardiology, Department of Internal Medicine University
More informationPCSK9 Antibodies for Dyslipidemia: Efficacy, Safety, and Non-Lipid Effects
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/lipid-luminations/pcsk9-antibodies-dyslipidemia-efficacy-safety-and-nonlipid-effects/8335/
More informationCardiovascular Management of a Patient with Diabetes
Cardiovascular Management of a Patient with Diabetes Dr Jeremy Krebs Clinical Leader Endocrinology and Diabetes Wellington Hospital Summary People with diabetes take a lot of medication Compliance and
More informationThe ERA JUMP Study: Reevaluating the Omega- 3 Index
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/lipid-luminations/the-era-jump-study-reevaluating-the-omega-3-
More informationDiabetic Eye Screening
Diabetic Eye Screening Lorraine Lockwood Engagement Manager Health Intelligence Classification: Internal / Public 26/10/16 Who we are (EDESP) formed on 1 st April 2016 Who should be screened? All patients
More informationChronic Benefit Application Form Cardiovascular Disease and Diabetes
Chronic Benefit Application Form Cardiovascular Disease and Diabetes 19 West Street, Houghton, South Africa, 2198 Postnet Suite 411, Private Bag X1, Melrose Arch, 2076 Tel: +27 (11) 715 3000 Fax: +27 (11)
More informationDiabetes and Heart Disease Awareness. Washington Newsletter Fall 2011
Diabetes and Heart Disease Awareness Healthy Living with Diabetes sm and Heart Healthy Living sm Washington Newsletter Fall 2011 Heart Disease What do a balanced diet, exercise, weight control and not
More informationDiabetic Eye Disease
Manchester Royal Eye Hospital Medical Retinal Services Information for Patients Diabetic Eye Disease This leaflet sets out to answer some of your questions about diabetic eye disease. You may wish to discuss
More informationCare Bundle. Adult patients with Type 2 Diabetes
Care Bundle Adult patients with Type 2 Diabetes July 2014 What is a care bundle? A care bundle is a set of interventions that, when used together, significantly improve patient outcomes. The measures chosen
More informationTorbay Children s Diabetes Service
Torbay Children s Diabetes Service Preventing Diabetes Complications Retinopathy Stroke Gum Disease Nephropathy Cardiovascular disease Neuropathy Diabetes Complications Thinking and talking about the possibility
More informationDiabetes Complications. Rezvan Salehidoost, M.D., Endocrinologist
Diabetes Complications Rezvan Salehidoost, M.D., Endocrinologist Different Diabetes Complications Macro vascular Micro vascular Infections Macro vascular Complications Macro-vascular Complications Ischemic
More informationFive chapters 1. What is CVD prevention 2. Why is CVD prevention needed 3. Who needs CVD prevention 4. How is CVD prevention applied 5. Where should CVD prevention be offered Shorter, more adapted to clinical
More informationPreparing for laser treatment for diabetic retinopathy and maculopathy
Preparing for laser treatment for diabetic retinopathy and maculopathy Information for patients Preparing for laser treatment for diabetic retinopathy and maculopathy. This leaflet sets out to answer the
More informationPharmaceutical Care of people with heart failure. Course activities
Pharmaceutical Care of people with heart failure Course activities Pharmaceutical Care of people with heart failure Course activities page 3 Case Study 1 5 Case Study 2 7 Case Study 3 9 Case Study 4 Case
More informationCV Risk Management in Diabetes Mellitus
CV Risk Management in Diabetes Mellitus J R Minkoff MD, FACP Endocrinology Clinical Professor of Family and Community Medicine University of California, San Francisco Mr. B 40 y/o Latino male c/o fatigue,
More informationEssential advice for men with diabetes from Accu-Chek. Man talk
Essential advice for men with diabetes from Accu-Chek Man talk Diabetes and ere More than 50% of m problems either obtai an erection. Whether you have diabetes or not, erectile dysfunction is a really
More informationHow to Reduce CVD Complications in Diabetes?
How to Reduce CVD Complications in Diabetes? Chaicharn Deerochanawong M.D. Diabetes and Endocrinology Unit Department of Medicine Rajavithi Hospital, Ministry of Public Health Framingham Heart Study 30-Year
More informationHIGH BLOOD PRESSURE. What is malignant or accelerated hypertension?
HIGH BLOOD PRESSURE Is high blood pressure important? What is blood pressure? What is high blood pressure? What are the causes of high blood pressure? What are the symptoms of high blood pressure? What
More informationDiabetes and Kidney Disease. Kris Bentley Renal Nurse practitioner 2018
Diabetes and Kidney Disease Kris Bentley Renal Nurse practitioner 2018 Aims Develop an understanding of Chronic Kidney Disease Understand how diabetes impacts on your kidneys Be able to recognise the risk
More informationSection 4 Decision-making
Decision-making : Decision-making Summary Conversations about treatments Participants were asked to describe the conversation that they had with the clinician about treatment at diagnosis. The most common
More informationCARDIOVASCULAR RISK FACTOR CONTROL IN TYPE 2 DIABETES MELLITUS AND NEW TRIAL EVIDENCE
CARDIOVASCULAR RISK FACTOR CONTROL IN TYPE 2 DIABETES MELLITUS AND NEW TRIAL EVIDENCE *Peter M. Nilsson Department of Clinical Sciences, Lund University, Skåne University Hospital, Malmö, Sweden *Correspondence
More informationSurveillance of Abdominal Aortic Aneurysms (AAA)
Surveillance of Abdominal Aortic Aneurysms (AAA) Exceptional healthcare, personally delivered This leaflet tells you about small abdominal aortic aneurysms. What is the aorta? The aorta is the largest
More informationStaying steady. Health & wellbeing. Improving your strength and balance. AgeUKIG14
Staying steady Improving your strength and balance Health & wellbeing AgeUKIG14 Age UK is the new force combining Age Concern and Help the Aged. With almost 120 years of combined history to draw on, we
More informationMaking Your Treatment Work Long-Term
Making Your Treatment Work Long-Term How to keep your treatment working... and why you don t want it to fail Regardless of the particular drugs you re taking, your drugs will only work when you take them.
More informationCombining Individualized Treatment Options with Patient-Clinician Dialogue
Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including
More informationNumber of people with diabetes
Written evidence from Diabetes UK DIABETES: THE BIGGEST HEALTH CHALLENGE OF OUR TIME A SYSTEM IN CRISIS 1. The Rising Tide of Diabetes and the Challenge for the NHS 2.1 Diabetes has become one of the biggest
More informationPrimary Prevention of Cardiovascular Disease (CVD) Events with Statins. 1 Primary Prevention of Cardiovascular Disease (CVD) Events with Statins
Primary Prevention of Cardiovascular Disease (CVD) Events with Statins 1 Primary Prevention of Cardiovascular Disease (CVD) Events with Statins 2 Welcome by Michael Pignone, MD, MPH Hi, my name is Dr.
More informationNews. Diabetes in the news: A guide to reporting on diabetes
News Diabetes in the news: A guide to reporting on diabetes Contents How we can help you What we do for people with diabetes What is diabetes? Why diabetes is a big issue A diabetes crisis in the UK Top
More informationFigures recently published by THE NHS DIABETES PREVENTION PROGRAMME A PROGRESS REPORT FEATURE
Physical activity is a core goal in prevention of Type 2 diabetes THE NHS DIABETES PROGRAMME A PROGRESS REPORT Louise Ansari, Director of Prevention at Diabetes UK and member of the NHS Diabetes Prevention
More informationChecking services for young people who drink alcohol and get into trouble In England and Wales
Checking services for young people who drink alcohol and get into trouble In England and Wales Original document title: A Joint Inspection of Youth Alcohol Misuse and Offending, by the Care Quality Commission,
More informationPersonal Diabetes Passport
Personal Diabetes Passport Contact information: Name: Physician: Diabetes Education Centre: Dietitian: Ophthalmologist: Chiropodist: Type of Diabetes: Type 1 (T1DM) Increased risk for diabetes Type 2(T2DM)
More informationPneumococcal Vaccines: Questions and Answers
Pneumococcal Vaccines: Questions and s Question 1 What is pneumococcal disease? What is pneumococcal disease? So pneumococcal disease is a group of diseases that are caused by a bacteria. Most of us are
More informationIndicator Points Payment stages. HF 1: The practice can produce a register of patients with 4 heart failure
Heart failure Indicator Points Payment stages Records HF 1: The practice can produce a register of patients with 4 heart failure Initial diagnosis HF 2: The percentage of patients with a diagnosis of heart
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME Briefing paper QOF indicator area: Primary prevention of CVD Potential output:
More informationThe contractor establishes and maintains a register of patients with AF
Atrial Fibrillation The contractor establishes and maintains a register of patients with AF G5731 Those patients with AF in whom there is a record of CHADS2 score of 1, the % of patients who are currently
More informationDIABETES COMPLICATIONS PROMPT DECK. stack the deck. against diabetes complications
DIABETES COMPLICATIONS PROMPT DECK stack the deck against diabetes complications EYE DISEASE KIDNEY DISEASE HEART DISEASE NERVE DAMAGE USING THE CARDS: CATEGORIES OTHER COMPLICATIONS SCENARIOS Q&A Discussion
More information4. resisted training ** OR resistance training * OR resisted exercise ** OR resistance exercise ** OR strength training ** OR strength exercise **
Supplementary Table 1. Search strategy (up to January 10 th 2015). MEDLINE Result: 253 studies 1. clinical trial ** OR controlled trial ** OR randomized controlled trial * OR randomised controlled trial
More informationGenetic Counselor: Hi Lisa. Hi Steve. Thanks for coming in today. The BART results came back and they are positive.
Hi, I m Kaylene Ready, a genetic counselor who specializes in the education and counseling of individuals at high-risk for hereditary breast and ovarian cancer syndrome. Women with an inherited BRCA 1
More informationAdvanced Chronic Kidney Disease and Secondary Hyperparathyroidism (HPT): Multidisciplinary Management
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/medical-industry-feature/advanced-chronic-kidney-disease-andsecondary-hyperparathyroidism-multi-disciplinary-management/9570/
More information